Dementia Diagnoses and Treatment in Geriatric Ward Patients: A Cross-Sectional Study in Poland
- PMID: 33223824
- PMCID: PMC7671484
- DOI: 10.2147/CIA.S281723
Dementia Diagnoses and Treatment in Geriatric Ward Patients: A Cross-Sectional Study in Poland
Abstract
Purpose: The study aimed to determine the prevalence of dementia, its types, and treatment in geriatric ward patients.
Patients and methods: A cross-sectional study of 406 patients (77.8% women, median age 82, IQR (77-86) years) who underwent a comprehensive geriatric assessment in one of the Polish hospitals between September 2014 and April 2015 was conducted.
Results: Dementia was diagnosed in 132 (32.5%) patients (46% mixed dementia; 32% Alzheimer's disease; 10%vascular dementia; 5% dementia in Parkinson's disease; 4% frontotemporal; 3% atypical parkinsonism). A total of 95 (72%) dementia cases were not detected before, and in the above half of these patients, it was not mentioned in the referral document. Only 33.3% of dementia patients were on cognitive enhancers (donepezil, rivastigmine, or memantine); 36.4% received antipsychotics, 45.5% received anti-depressants, 25.8% received nootropics, and 16.7% received anxiolytics/hypnotics.
Discussion: The results confirmed the high incidence of underdiagnoses and undertreatment of dementia in patients admitted to the geriatric ward. It is partly due to the lack of systematic cognitive assessment in primary care settings, although other factors can play a role.
Keywords: anti-dementia medications; anti-depressants; antipsychotics; cognitive enhancers; comprehensive geriatric assessment; dementia diagnosis; dementia treatment; geriatric ward; psychotropic medications; underdiagnoses; undertreatment.
© 2020 Wojszel.
Conflict of interest statement
The author reports no conflicts of interest for this work.
Figures




Similar articles
-
Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study.Drugs Aging. 2010 Nov 1;27(11):903-13. doi: 10.2165/11584290-000000000-00000. Drugs Aging. 2010. PMID: 20964464
-
One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland.J Alzheimers Dis. 2019;70(3):899-905. doi: 10.3233/JAD-190508. J Alzheimers Dis. 2019. PMID: 31306136
-
Is drug treatment for dementia followed up in primary care? A Swedish study of dementia clinics and referring primary care centres.PLoS One. 2013;8(2):e57161. doi: 10.1371/journal.pone.0057161. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437334 Free PMC article.
-
[Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].Neuropsychiatr. 2010;24(2):67-87. Neuropsychiatr. 2010. PMID: 20605003 German.
-
Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):300-6. doi: 10.1684/pnv.2016.0621. Geriatr Psychol Neuropsychiatr Vieil. 2016. PMID: 27651011 Review. English.
Cited by
-
Prevalence of Severe Neurocognitive Impairment and Its Association with Socio-Demographics and Functionality Among Ugandan Older Persons: A Hospital-Based Study.Clin Interv Aging. 2021 Jul 22;16:1415-1425. doi: 10.2147/CIA.S319891. eCollection 2021. Clin Interv Aging. 2021. PMID: 34326633 Free PMC article.
-
Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study.Front Psychiatry. 2022 Nov 24;13:1050583. doi: 10.3389/fpsyt.2022.1050583. eCollection 2022. Front Psychiatry. 2022. PMID: 36506451 Free PMC article.
-
Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation.Front Cardiovasc Med. 2021 Dec 24;8:805234. doi: 10.3389/fcvm.2021.805234. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 35004915 Free PMC article.
References
-
- Duckett L. Alzheimer’s dementia: morbidity and mortality. J Insur Med. 2001;33(3):227–234. - PubMed
-
- Wancata J, Freidl M, Unger A, et al. [Projections about the future number of dementia sufferers: increasing life expectancy not sufficiently considered?]. Psychiatr Danub. 2015;27(4):452–457. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous